RecruitingPhase 2Phase 3NCT06566508

Effectiveness of Asiaticoside as Intracanal Medication on Infectious/Inflammatory Contents in Teeth With Apical Periodontitis


Sponsor

Mansoura University

Enrollment

36 participants

Start Date

Nov 20, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this study is to investigate \"clinically\" the effectiveness of Asiaticoside based intracanal medication compared to the commonly used intracanal medicaments (calcium hydroxide Ca(OH)2 and Ledermix) on the levels of bacteria and inflammatory cytokines in root canals and periradicular tissues of teeth with apical periodontitis.


Eligibility

Min Age: 20 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Asiaticoside Intracanal medication, a drug called Calcium Hydroxide Intracanal medication, and others for people with intracanal medication. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCalcium Hydroxide Intracanal medication

Calcium Hydroxide Intracanal medication

DRUGLeddermix Intracanal medication

Leddermix Intracanal medication

DRUGAsiaticoside Intracanal medication

Asiaticoside Intracanal medication


Locations(1)

Mansoura university

Al Mansurah, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06566508


Related Trials